Ledger.Open graph →
SEC Form D · filed May 1, 2014

ProNAi Therapeutics Inc

Offering
$59.5M
Sold
$59.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Plymouth, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Donald Parfet · Plymouth, MIDirectorAlvin Vitangcol · Plymouth, MIDirectorMina Sooch · Plymouth, MIExecWendi Rodrigueza · Plymouth, MIExecJames Topper · Seattle, WADirectorPeter Thompson · Seattle, WADirectorRoderick M. Forrest · Hamilton, BermudaExecWindham Capital Management LLC · Boston, MADirectorMustafa J. Al Lawati · DUBAI, C0DirectorAli J. Al Lawati · DUBAI, C0ExecAlbert Cha · DUBLIN, CADirectorRichard Messmann · Plymouth, MIExecJames Topper · Newton, MADirectorPeter Thompson · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗